Medical Health Cluster

Delta Variant’s

Several Existing Drugs Reduce Delta Variant’s Ability To Replicate in Human Cells 

Several FDA-approved drugs — including for type 2 diabetes, hepatitis C and HIV — significantly reduce the ability of the Delta variant of SARS-CoV-2 to replicate in human cells, according to new research led by scientists at Penn State. Specifically, the team found that these drugs inhibit certain viral enzymes, […]

Read More

New Clues to Delta Variant’s Spread in Studies of Virus-Like Particles

About 70,000 people in the United States are diagnosed with COVID-19 each and every day. It’s clear that these new cases are being driven by the more-infectious Delta variant of SARS-CoV-2, the novel coronavirus that causes COVID-19. But why does the Delta variant spread more easily than other viral variants […]

Read More